Rui Zhou

机构：The First People's Hospital of Shunde · ORCID：0000-0002-4880-0563

发表论文 59 篇 · 总被引 939 次 · h-index 17

代表论文

• Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer (2022 · Frontiers in Immunology · 被引 180)
• Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study (2025 · The Lancet Respiratory Medicine · 被引 17)
• The activity of cuproptosis pathway calculated by AUCell algorithm was employed to construct cuproptosis landscape in lung adenocarcinoma (2023 · Discover Oncology · 被引 15)
• Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes (2024 · Cardiovascular Diabetology · 被引 14)
• Whole exome sequencing reveals novel variants associated with diminished ovarian reserve in young women (2023 · Frontiers in Genetics · 被引 12)
• Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes (2022 · BMC Bioinformatics · 被引 11)